Company · CIK 0001609809 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Seres Therapeutics, Inc. · MCRB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 SForm 4 → | Aug 18, 5:33 pm EDT | Kelly BradySee Remarks | 64 | $4.55 | $291 | 8,679 | −0.73% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 5:27 pm EDT | Eric D. ShaffDirector | 263 | $4.55 | $1,197 | 12,499 | −2.06% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 5:25 pm EDT | Matthew R HennSee Remarks | 81 | $4.55 | $369 | 7,995 | −1.00% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 5:22 pm EDT | Thomas DesRosierSee Remarks | 82 | $4.55 | $373 | 8,117 | −1.00% | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 5:33 pm EDT | Kelly BradySee Remarks | 181 | — | — | 8,743 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 5:27 pm EDT | Eric D. ShaffDirector | 722 | — | — | 12,762 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 5:25 pm EDT | Matthew R HennSee Remarks | 238 | — | — | 8,076 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 5:22 pm EDT | Thomas DesRosierSee Remarks | 245 | — | — | 8,199 | — | 10b5-1 |